JPH0430955B2 - - Google Patents
Info
- Publication number
- JPH0430955B2 JPH0430955B2 JP17257084A JP17257084A JPH0430955B2 JP H0430955 B2 JPH0430955 B2 JP H0430955B2 JP 17257084 A JP17257084 A JP 17257084A JP 17257084 A JP17257084 A JP 17257084A JP H0430955 B2 JPH0430955 B2 JP H0430955B2
- Authority
- JP
- Japan
- Prior art keywords
- amino
- compound according
- tetrazolyl
- benzodioxane
- group
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 150000001875 compounds Chemical class 0.000 claims description 365
- 125000004432 carbon atom Chemical group C* 0.000 claims description 155
- 125000000217 alkyl group Chemical group 0.000 claims description 84
- 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 claims description 71
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 71
- BNBQRQQYDMDJAH-UHFFFAOYSA-N benzodioxan Chemical compound C1=CC=C2OCCOC2=C1 BNBQRQQYDMDJAH-UHFFFAOYSA-N 0.000 claims description 44
- -1 2-tetrazolylmethyl group Chemical group 0.000 claims description 38
- 125000003545 alkoxy group Chemical group 0.000 claims description 33
- 125000005843 halogen group Chemical group 0.000 claims description 29
- LYKMMUBOEFYJQG-UHFFFAOYSA-N piperoxan Chemical compound C1OC2=CC=CC=C2OC1CN1CCCCC1 LYKMMUBOEFYJQG-UHFFFAOYSA-N 0.000 claims description 26
- 125000003342 alkenyl group Chemical group 0.000 claims description 23
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 23
- OTAFHZMPRISVEM-UHFFFAOYSA-N chromone Chemical compound C1=CC=C2C(=O)C=COC2=C1 OTAFHZMPRISVEM-UHFFFAOYSA-N 0.000 claims description 22
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims description 19
- 150000003839 salts Chemical class 0.000 claims description 19
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 18
- 125000003302 alkenyloxy group Chemical group 0.000 claims description 15
- 125000000304 alkynyl group Chemical group 0.000 claims description 15
- 150000002617 leukotrienes Chemical class 0.000 claims description 15
- 125000004430 oxygen atom Chemical group O* 0.000 claims description 14
- 150000001732 carboxylic acid derivatives Chemical class 0.000 claims description 12
- 238000004519 manufacturing process Methods 0.000 claims description 12
- 125000004414 alkyl thio group Chemical group 0.000 claims description 11
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims description 11
- 231100000252 nontoxic Toxicity 0.000 claims description 11
- 230000003000 nontoxic effect Effects 0.000 claims description 11
- 125000004434 sulfur atom Chemical group 0.000 claims description 11
- YTPLMLYBLZKORZ-UHFFFAOYSA-N Thiophene Chemical group C=1C=CSC=1 YTPLMLYBLZKORZ-UHFFFAOYSA-N 0.000 claims description 10
- 150000001408 amides Chemical class 0.000 claims description 10
- 229910052717 sulfur Inorganic materials 0.000 claims description 10
- KYNSBQPICQTCGU-UHFFFAOYSA-N Benzopyrane Chemical compound C1=CC=C2C=CCOC2=C1 KYNSBQPICQTCGU-UHFFFAOYSA-N 0.000 claims description 9
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 claims description 9
- 125000004494 ethyl ester group Chemical group 0.000 claims description 9
- 125000005133 alkynyloxy group Chemical group 0.000 claims description 7
- 125000005708 carbonyloxy group Chemical group [*:2]OC([*:1])=O 0.000 claims description 7
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims description 7
- 229910052757 nitrogen Inorganic materials 0.000 claims description 7
- 229910052799 carbon Inorganic materials 0.000 claims description 6
- 238000005886 esterification reaction Methods 0.000 claims description 6
- 125000005677 ethinylene group Chemical group [*:2]C#C[*:1] 0.000 claims description 5
- 125000004433 nitrogen atom Chemical group N* 0.000 claims description 5
- 238000007127 saponification reaction Methods 0.000 claims description 5
- 125000003831 tetrazolyl group Chemical group 0.000 claims description 5
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 4
- 239000004480 active ingredient Substances 0.000 claims description 4
- 125000003277 amino group Chemical group 0.000 claims description 4
- 150000001540 azides Chemical class 0.000 claims description 4
- 125000000753 cycloalkyl group Chemical group 0.000 claims description 4
- 125000005678 ethenylene group Chemical group [H]C([*:1])=C([H])[*:2] 0.000 claims description 4
- 125000001183 hydrocarbyl group Chemical group 0.000 claims description 4
- 125000001570 methylene group Chemical group [H]C([H])([*:1])[*:2] 0.000 claims description 4
- 229910052760 oxygen Inorganic materials 0.000 claims description 4
- 239000001301 oxygen Substances 0.000 claims description 4
- 125000003884 phenylalkyl group Chemical group 0.000 claims description 4
- 125000004183 alkoxy alkyl group Chemical group 0.000 claims description 3
- 125000005083 alkoxyalkoxy group Chemical group 0.000 claims description 3
- 239000005557 antagonist Substances 0.000 claims description 3
- IVRMZWNICZWHMI-UHFFFAOYSA-N azide group Chemical group [N-]=[N+]=[N-] IVRMZWNICZWHMI-UHFFFAOYSA-N 0.000 claims description 3
- 125000000852 azido group Chemical group *N=[N+]=[N-] 0.000 claims description 3
- 125000001316 cycloalkyl alkyl group Chemical group 0.000 claims description 3
- 125000005112 cycloalkylalkoxy group Chemical group 0.000 claims description 3
- 230000032050 esterification Effects 0.000 claims description 3
- VAOABFFKRMVKOB-UHFFFAOYSA-N 6-[4-[[3-(2h-tetrazol-5-yl)-2,3-dihydro-1,4-benzodioxin-5-yl]carbamoyl]phenoxy]hexyl acetate Chemical compound C1=CC(OCCCCCCOC(=O)C)=CC=C1C(=O)NC1=CC=CC2=C1OC(C=1NN=NN=1)CO2 VAOABFFKRMVKOB-UHFFFAOYSA-N 0.000 claims description 2
- 125000005569 butenylene group Chemical group 0.000 claims description 2
- 125000004663 dialkyl amino group Chemical group 0.000 claims description 2
- RMGVZKRVHHSUIM-UHFFFAOYSA-N dithionic acid Chemical compound OS(=O)(=O)S(O)(=O)=O RMGVZKRVHHSUIM-UHFFFAOYSA-N 0.000 claims description 2
- 125000000951 phenoxy group Chemical group [H]C1=C([H])C([H])=C(O*)C([H])=C1[H] 0.000 claims description 2
- 125000003356 phenylsulfanyl group Chemical group [*]SC1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 claims description 2
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims description 2
- 125000001501 propionyl group Chemical group O=C([*])C([H])([H])C([H])([H])[H] 0.000 claims description 2
- 159000000000 sodium salts Chemical class 0.000 claims description 2
- LITCMHPQYJGSFC-UHFFFAOYSA-N 3-(2h-tetrazol-5-yl)-2h-1,4-benzodioxin-3-amine Chemical compound C1OC2=CC=CC=C2OC1(N)C1=NN=NN1 LITCMHPQYJGSFC-UHFFFAOYSA-N 0.000 claims 20
- JCIDEANDDNSHQC-UHFFFAOYSA-N 4H-chromene Chemical compound C1=CC=C2CC=COC2=C1 JCIDEANDDNSHQC-UHFFFAOYSA-N 0.000 claims 8
- GGRBXOWLFXBECG-UHFFFAOYSA-N 5-(2,3-dihydro-1,4-benzodioxin-3-yl)-2h-tetrazole Chemical compound C1OC2=CC=CC=C2OC1C=1N=NNN=1 GGRBXOWLFXBECG-UHFFFAOYSA-N 0.000 claims 7
- 150000004702 methyl esters Chemical class 0.000 claims 4
- HTXQVFXXVXOLCF-UHFFFAOYSA-N 6-methylchromen-4-one Chemical compound O1C=CC(=O)C2=CC(C)=CC=C21 HTXQVFXXVXOLCF-UHFFFAOYSA-N 0.000 claims 3
- PXPNSQMWVPLERM-UHFFFAOYSA-N 2-methylchromen-4-one Chemical compound C1=CC=C2OC(C)=CC(=O)C2=C1 PXPNSQMWVPLERM-UHFFFAOYSA-N 0.000 claims 2
- HGBUQTOGNIRVHU-UHFFFAOYSA-N 3-(4-pentylphenyl)-n-[3-(2h-tetrazol-5-yl)-2,3-dihydro-1,4-benzodioxin-5-yl]prop-2-enamide Chemical compound C1=CC(CCCCC)=CC=C1C=CC(=O)NC1=CC=CC2=C1OC(C1=NNN=N1)CO2 HGBUQTOGNIRVHU-UHFFFAOYSA-N 0.000 claims 2
- ROHMBASLHILJFK-UHFFFAOYSA-N 2-pentoxy-n-[3-(2h-tetrazol-5-yl)-2,3-dihydro-1,4-benzodioxin-5-yl]benzamide Chemical compound CCCCCOC1=CC=CC=C1C(=O)NC1=CC=CC2=C1OC(C=1NN=NN=1)CO2 ROHMBASLHILJFK-UHFFFAOYSA-N 0.000 claims 1
- DWULGIQYOMUEAN-UHFFFAOYSA-N 3-(2-pentylphenyl)-n-[3-(2h-tetrazol-5-yl)-2,3-dihydro-1,4-benzodioxin-5-yl]prop-2-enamide Chemical compound CCCCCC1=CC=CC=C1C=CC(=O)NC1=CC=CC2=C1OC(C1=NNN=N1)CO2 DWULGIQYOMUEAN-UHFFFAOYSA-N 0.000 claims 1
- YBABDDMQWBJFPH-UHFFFAOYSA-N 3-(3-methoxy-4-pentoxyphenyl)-n-[3-(2h-tetrazol-5-yl)-2,3-dihydro-1,4-benzodioxin-5-yl]prop-2-enamide Chemical compound C1=C(OC)C(OCCCCC)=CC=C1C=CC(=O)NC1=CC=CC2=C1OC(C1=NNN=N1)CO2 YBABDDMQWBJFPH-UHFFFAOYSA-N 0.000 claims 1
- TWHHLJSHRKLRCH-UHFFFAOYSA-N 3-(3-octylphenyl)-n-[3-(2h-tetrazol-5-yl)-2,3-dihydro-1,4-benzodioxin-5-yl]prop-2-enamide Chemical compound CCCCCCCCC1=CC=CC(C=CC(=O)NC=2C=3OC(COC=3C=CC=2)C2=NNN=N2)=C1 TWHHLJSHRKLRCH-UHFFFAOYSA-N 0.000 claims 1
- MGYZMMFPQHHKTJ-UHFFFAOYSA-N 3-(4-butoxyphenyl)-n-[3-(2h-tetrazol-5-yl)-2,3-dihydro-1,4-benzodioxin-5-yl]prop-2-enamide Chemical compound C1=CC(OCCCC)=CC=C1C=CC(=O)NC1=CC=CC2=C1OC(C1=NNN=N1)CO2 MGYZMMFPQHHKTJ-UHFFFAOYSA-N 0.000 claims 1
- QSEWBONWOPSITJ-UHFFFAOYSA-N 3-(4-butylphenyl)-n-[3-(2h-tetrazol-5-yl)-2,3-dihydro-1,4-benzodioxin-5-yl]prop-2-enamide Chemical compound C1=CC(CCCC)=CC=C1C=CC(=O)NC1=CC=CC2=C1OC(C1=NNN=N1)CO2 QSEWBONWOPSITJ-UHFFFAOYSA-N 0.000 claims 1
- GCYSHIKPUSQCCV-UHFFFAOYSA-N 3-(4-decylphenyl)-n-[3-(2h-tetrazol-5-yl)-2,3-dihydro-1,4-benzodioxin-5-yl]prop-2-enamide Chemical compound C1=CC(CCCCCCCCCC)=CC=C1C=CC(=O)NC1=CC=CC2=C1OC(C1=NNN=N1)CO2 GCYSHIKPUSQCCV-UHFFFAOYSA-N 0.000 claims 1
- FMGLFXCMBZGPDL-UHFFFAOYSA-N 3-(4-ethylphenyl)-n-[3-(2h-tetrazol-5-yl)-2,3-dihydro-1,4-benzodioxin-5-yl]prop-2-enamide Chemical compound C1=CC(CC)=CC=C1C=CC(=O)NC1=CC=CC2=C1OC(C1=NNN=N1)CO2 FMGLFXCMBZGPDL-UHFFFAOYSA-N 0.000 claims 1
- PWEJTHONIDHCLI-UHFFFAOYSA-N 3-(4-hexylphenyl)-n-[3-(2h-tetrazol-5-yl)-2,3-dihydro-1,4-benzodioxin-5-yl]prop-2-enamide Chemical compound C1=CC(CCCCCC)=CC=C1C=CC(=O)NC1=CC=CC2=C1OC(C1=NNN=N1)CO2 PWEJTHONIDHCLI-UHFFFAOYSA-N 0.000 claims 1
- FOXMBBUVVFEBAX-UHFFFAOYSA-N 3-(4-nonylphenyl)-n-[3-(2h-tetrazol-5-yl)-2,3-dihydro-1,4-benzodioxin-5-yl]prop-2-enamide Chemical compound C1=CC(CCCCCCCCC)=CC=C1C=CC(=O)NC1=CC=CC2=C1OC(C1=NNN=N1)CO2 FOXMBBUVVFEBAX-UHFFFAOYSA-N 0.000 claims 1
- WZLAUXKXTLNMDW-UHFFFAOYSA-N 3-(4-octylphenyl)-n-[3-(2h-tetrazol-5-yl)-2,3-dihydro-1,4-benzodioxin-5-yl]prop-2-enamide Chemical compound C1=CC(CCCCCCCC)=CC=C1C=CC(=O)NC1=CC=CC2=C1OC(C1=NNN=N1)CO2 WZLAUXKXTLNMDW-UHFFFAOYSA-N 0.000 claims 1
- UGASCOSKCDZWOP-UHFFFAOYSA-N 3-(4-pentylphenyl)-n-[2-(2h-tetrazol-5-yl)-2,3-dihydro-1,4-benzodithiin-5-yl]prop-2-enamide Chemical compound C1=CC(CCCCC)=CC=C1C=CC(=O)NC1=CC=CC2=C1SCC(C1=NNN=N1)S2 UGASCOSKCDZWOP-UHFFFAOYSA-N 0.000 claims 1
- BPOYJKOITPOGHN-UHFFFAOYSA-N 3-(4-pentylphenyl)-n-[3-(2h-tetrazol-5-yl)-2,3-dihydro-1,4-benzodithiin-5-yl]prop-2-enamide Chemical compound C1=CC(CCCCC)=CC=C1C=CC(=O)NC1=CC=CC2=C1SC(C1=NNN=N1)CS2 BPOYJKOITPOGHN-UHFFFAOYSA-N 0.000 claims 1
- GHYJLDJJOTYUQB-UHFFFAOYSA-N 3-(4-propoxyphenyl)-n-[3-(2h-tetrazol-5-yl)-2,3-dihydro-1,4-benzodioxin-5-yl]prop-2-enamide Chemical compound C1=CC(OCCC)=CC=C1C=CC(=O)NC1=CC=CC2=C1OC(C1=NNN=N1)CO2 GHYJLDJJOTYUQB-UHFFFAOYSA-N 0.000 claims 1
- KAIRIRDEGZVHEP-UHFFFAOYSA-N 3-(4-propylphenyl)-n-[3-(2h-tetrazol-5-yl)-2,3-dihydro-1,4-benzodioxin-5-yl]prop-2-enamide Chemical compound C1=CC(CCC)=CC=C1C=CC(=O)NC1=CC=CC2=C1OC(C1=NNN=N1)CO2 KAIRIRDEGZVHEP-UHFFFAOYSA-N 0.000 claims 1
- AZCNARPKKPXNPR-UHFFFAOYSA-N 3-[2-methyl-4-(4-methylpentoxy)phenyl]-n-[3-(2h-tetrazol-5-yl)-2,3-dihydro-1,4-benzodioxin-5-yl]prop-2-enamide Chemical compound CC1=CC(OCCCC(C)C)=CC=C1C=CC(=O)NC1=CC=CC2=C1OC(C1=NNN=N1)CO2 AZCNARPKKPXNPR-UHFFFAOYSA-N 0.000 claims 1
- DGGSULIRXWPFKZ-UHFFFAOYSA-N 3-[4-(2-cyclohexylethoxy)phenyl]-n-[3-(2h-tetrazol-5-yl)-2,3-dihydro-1,4-benzodioxin-5-yl]prop-2-enamide Chemical compound C=1C=C(OCCC2CCCCC2)C=CC=1C=CC(=O)NC(C=1O2)=CC=CC=1OCC2C=1N=NNN=1 DGGSULIRXWPFKZ-UHFFFAOYSA-N 0.000 claims 1
- FYYXJYAQHSQJBS-UHFFFAOYSA-N 3-[4-(2-methylpropyl)phenyl]-n-[3-(2h-tetrazol-5-yl)-2,3-dihydro-1,4-benzodioxin-5-yl]prop-2-enamide Chemical compound C1=CC(CC(C)C)=CC=C1C=CC(=O)NC1=CC=CC2=C1OC(C1=NNN=N1)CO2 FYYXJYAQHSQJBS-UHFFFAOYSA-N 0.000 claims 1
- OMJKILYNTWEMKY-UHFFFAOYSA-N 3-[4-(4-cyclohexylbutoxy)phenyl]-n-[3-(2h-tetrazol-5-yl)-2,3-dihydro-1,4-benzodioxin-5-yl]prop-2-enamide Chemical compound C=1C=C(OCCCCC2CCCCC2)C=CC=1C=CC(=O)NC(C=1O2)=CC=CC=1OCC2C=1N=NNN=1 OMJKILYNTWEMKY-UHFFFAOYSA-N 0.000 claims 1
- IQDPAKOIAQDBLX-UHFFFAOYSA-N 3-[4-(4-methylpentoxy)-2-phenylphenyl]-n-[3-(2h-tetrazol-5-yl)-2,3-dihydro-1,4-benzodioxin-5-yl]prop-2-enamide Chemical compound C=1C=CC=CC=1C1=CC(OCCCC(C)C)=CC=C1C=CC(=O)NC(C=1O2)=CC=CC=1OCC2C=1N=NNN=1 IQDPAKOIAQDBLX-UHFFFAOYSA-N 0.000 claims 1
- KHNCBHCSSMKOGE-UHFFFAOYSA-N 3-[4-(4-methylpentoxy)phenyl]-n-[4-oxo-2-(2h-tetrazol-5-yl)chromen-8-yl]prop-2-enamide Chemical compound C1=CC(OCCCC(C)C)=CC=C1C=CC(=O)NC1=CC=CC2=C1OC(C1=NNN=N1)=CC2=O KHNCBHCSSMKOGE-UHFFFAOYSA-N 0.000 claims 1
- LCRGOVPUUUWMOL-UHFFFAOYSA-N 3-[4-(5-phenylpentoxy)phenyl]-n-[3-(2h-tetrazol-5-yl)-2,3-dihydro-1,4-benzodioxin-5-yl]prop-2-enamide Chemical compound C=1C=C(OCCCCCC=2C=CC=CC=2)C=CC=1C=CC(=O)NC(C=1O2)=CC=CC=1OCC2C=1N=NNN=1 LCRGOVPUUUWMOL-UHFFFAOYSA-N 0.000 claims 1
- MVUYWVDQCAWJIM-UHFFFAOYSA-N 3-amino-6-fluoro-2-(2H-tetrazol-5-yl)chromen-4-one Chemical compound NC1=C(OC2=C(C1=O)C=C(C=C2)F)C1=NN=NN1 MVUYWVDQCAWJIM-UHFFFAOYSA-N 0.000 claims 1
- JSBVWPNRYNKYFI-NTUHNPAUSA-N 3-chloro-4-[(e)-oct-1-enoxy]-n-[3-(2h-tetrazol-5-yl)-2,3-dihydro-1,4-benzodioxin-5-yl]benzamide Chemical compound C1=C(Cl)C(O/C=C/CCCCCC)=CC=C1C(=O)NC1=CC=CC2=C1OC(C1=NNN=N1)CO2 JSBVWPNRYNKYFI-NTUHNPAUSA-N 0.000 claims 1
- NKRNGXYZEZTQOE-UHFFFAOYSA-N 3-pentoxy-n-[3-(2h-tetrazol-5-yl)-2,3-dihydro-1,4-benzodioxin-5-yl]benzamide Chemical compound CCCCCOC1=CC=CC(C(=O)NC=2C=3OC(COC=3C=CC=2)C=2NN=NN=2)=C1 NKRNGXYZEZTQOE-UHFFFAOYSA-N 0.000 claims 1
- ICEMINZYWCXWCT-UHFFFAOYSA-N 3-pentyl-n-[3-(2h-tetrazol-5-yl)-2,3-dihydro-1,4-benzodioxin-5-yl]benzenecarbothioamide Chemical compound CCCCCC1=CC=CC(C(=S)NC=2C=3OC(COC=3C=CC=2)C=2NN=NN=2)=C1 ICEMINZYWCXWCT-UHFFFAOYSA-N 0.000 claims 1
- SXEZKGXFQBSILK-UHFFFAOYSA-N 4-(3,7-dimethyloctoxy)-n-[3-(2h-tetrazol-5-yl)-2,3-dihydro-1,4-benzodioxin-5-yl]benzamide Chemical compound C1=CC(OCCC(C)CCCC(C)C)=CC=C1C(=O)NC1=CC=CC2=C1OC(C=1NN=NN=1)CO2 SXEZKGXFQBSILK-UHFFFAOYSA-N 0.000 claims 1
- SIKGFXVWCAHOND-UHFFFAOYSA-N 4-(3-phenylprop-2-enoxy)-n-[3-(2h-tetrazol-5-yl)-2,3-dihydro-1,4-benzodioxin-5-yl]benzamide Chemical compound C=1C=C(OCC=CC=2C=CC=CC=2)C=CC=1C(=O)NC(C=1O2)=CC=CC=1OCC2C=1N=NNN=1 SIKGFXVWCAHOND-UHFFFAOYSA-N 0.000 claims 1
- XEOHUSDYIHFREO-UHFFFAOYSA-N 4-(3-phenylsulfanylpropoxy)-n-[3-(2h-tetrazol-5-yl)-2,3-dihydro-1,4-benzodioxin-5-yl]benzamide Chemical compound C=1C=C(OCCCSC=2C=CC=CC=2)C=CC=1C(=O)NC(C=1O2)=CC=CC=1OCC2C1=NN=NN1 XEOHUSDYIHFREO-UHFFFAOYSA-N 0.000 claims 1
- ONSIRBRNAGFNKF-UHFFFAOYSA-N 4-(4-chlorobutoxy)-n-[4-oxo-2-(2h-tetrazol-5-yl)chromen-8-yl]benzamide Chemical compound C1=CC(OCCCCCl)=CC=C1C(=O)NC1=CC=CC2=C1OC(C=1NN=NN=1)=CC2=O ONSIRBRNAGFNKF-UHFFFAOYSA-N 0.000 claims 1
- YNKGMCPQHSVJBM-UHFFFAOYSA-N 4-(6-hydroxyhexoxy)-n-[3-(2h-tetrazol-5-yl)-2,3-dihydro-1,4-benzodioxin-5-yl]benzamide Chemical compound C1=CC(OCCCCCCO)=CC=C1C(=O)NC1=CC=CC2=C1OC(C=1NN=NN=1)CO2 YNKGMCPQHSVJBM-UHFFFAOYSA-N 0.000 claims 1
- DFVKZBJIWBRFMN-CSNJMMPQSA-N 4-[(1e,3e)-octa-1,3-dienoxy]-n-[3-(2h-tetrazol-5-yl)-2,3-dihydro-1,4-benzodioxin-5-yl]benzamide Chemical compound C1=CC(O/C=C/C=C/CCCC)=CC=C1C(=O)NC1=CC=CC2=C1OC(C1=NNN=N1)CO2 DFVKZBJIWBRFMN-CSNJMMPQSA-N 0.000 claims 1
- QLGKJENFCAUWEO-NBVRZTHBSA-N 4-[(2e)-3,7-dimethylocta-2,6-dienoxy]-n-[3-(2h-tetrazol-5-yl)-2,3-dihydro-1,4-benzodioxin-5-yl]benzamide Chemical compound C1=CC(OC/C=C(C)/CCC=C(C)C)=CC=C1C(=O)NC1=CC=CC2=C1OC(C=1NN=NN=1)CO2 QLGKJENFCAUWEO-NBVRZTHBSA-N 0.000 claims 1
- QZGPHIPRWAQPCF-UHFFFAOYSA-N 4-[5-(dimethylamino)pentoxy]-n-[3-(2h-tetrazol-5-yl)-2,3-dihydro-1,4-benzodioxin-5-yl]benzamide Chemical compound C1=CC(OCCCCCN(C)C)=CC=C1C(=O)NC1=CC=CC2=C1OC(C1=NNN=N1)CO2 QZGPHIPRWAQPCF-UHFFFAOYSA-N 0.000 claims 1
- OKPACELMVBBRER-UHFFFAOYSA-N 4-butoxy-n-[3-(2h-tetrazol-5-yl)-2,3-dihydro-1,4-benzodioxin-5-yl]benzamide Chemical compound C1=CC(OCCCC)=CC=C1C(=O)NC1=CC=CC2=C1OC(C=1NN=NN=1)CO2 OKPACELMVBBRER-UHFFFAOYSA-N 0.000 claims 1
- PULYGNHSSUPCKL-UHFFFAOYSA-N 4-decoxy-n-[3-(2h-tetrazol-5-yl)-2,3-dihydro-1,4-benzodioxin-5-yl]benzamide Chemical compound C1=CC(OCCCCCCCCCC)=CC=C1C(=O)NC1=CC=CC2=C1OC(C=1NN=NN=1)CO2 PULYGNHSSUPCKL-UHFFFAOYSA-N 0.000 claims 1
- AIANCPCQGZTGKM-UHFFFAOYSA-N 4-heptoxy-n-[3-(2h-tetrazol-5-yl)-2,3-dihydro-1,4-benzodioxin-5-yl]benzamide Chemical compound C1=CC(OCCCCCCC)=CC=C1C(=O)NC1=CC=CC2=C1OC(C=1NN=NN=1)CO2 AIANCPCQGZTGKM-UHFFFAOYSA-N 0.000 claims 1
- KEAPEQBCDVILQF-UHFFFAOYSA-N 4-hexoxy-n-[3-(2h-tetrazol-5-yl)-2,3-dihydro-1,4-benzodioxin-5-yl]benzamide Chemical compound C1=CC(OCCCCCC)=CC=C1C(=O)NC1=CC=CC2=C1OC(C=1NN=NN=1)CO2 KEAPEQBCDVILQF-UHFFFAOYSA-N 0.000 claims 1
- YBNVSQIAVPPCOR-UHFFFAOYSA-N 4-nonoxy-n-[3-(2h-tetrazol-5-yl)-2,3-dihydro-1,4-benzodioxin-5-yl]benzamide Chemical compound C1=CC(OCCCCCCCCC)=CC=C1C(=O)NC1=CC=CC2=C1OC(C=1NN=NN=1)CO2 YBNVSQIAVPPCOR-UHFFFAOYSA-N 0.000 claims 1
- IWEUQSCUBLQJOC-UHFFFAOYSA-N 4-octoxy-n-[3-(2h-tetrazol-5-yl)-2,3-dihydro-1,4-benzodioxin-5-yl]benzamide Chemical compound C1=CC(OCCCCCCCC)=CC=C1C(=O)NC1=CC=CC2=C1OC(C=1NN=NN=1)CO2 IWEUQSCUBLQJOC-UHFFFAOYSA-N 0.000 claims 1
- JZZDREMYWFXVHI-UHFFFAOYSA-N 4-oxo-8-[(4-pentylbenzoyl)amino]chromene-2-carboxylic acid Chemical compound C1=CC(CCCCC)=CC=C1C(=O)NC1=CC=CC2=C1OC(C(O)=O)=CC2=O JZZDREMYWFXVHI-UHFFFAOYSA-N 0.000 claims 1
- NATABTMCIQIPPL-UHFFFAOYSA-N 4-pentoxy-n-[3-(2h-tetrazol-5-yl)-2,3-dihydro-1,4-benzodioxin-5-yl]benzamide Chemical compound C1=CC(OCCCCC)=CC=C1C(=O)NC1=CC=CC2=C1OC(C=1NN=NN=1)CO2 NATABTMCIQIPPL-UHFFFAOYSA-N 0.000 claims 1
- NUIVLNLSOSEGIA-UHFFFAOYSA-N 4-pentyl-n-[3-(2h-tetrazol-5-yl)-2,3-dihydro-1,4-benzodioxin-5-yl]benzenecarbothioamide Chemical compound C1=CC(CCCCC)=CC=C1C(=S)NC1=CC=CC2=C1OC(C=1NN=NN=1)CO2 NUIVLNLSOSEGIA-UHFFFAOYSA-N 0.000 claims 1
- CJRXCVZFRUKNKT-UHFFFAOYSA-N 4-propoxy-n-[3-(2h-tetrazol-5-yl)-2,3-dihydro-1,4-benzodioxin-5-yl]benzamide Chemical compound C1=CC(OCCC)=CC=C1C(=O)NC1=CC=CC2=C1OC(C=1NN=NN=1)CO2 CJRXCVZFRUKNKT-UHFFFAOYSA-N 0.000 claims 1
- VBTYYGFMXUENNQ-UHFFFAOYSA-N 5-[(4-octoxybenzoyl)amino]-2,3-dihydro-1,4-benzodioxine-3-carboxylic acid Chemical compound C1=CC(OCCCCCCCC)=CC=C1C(=O)NC1=CC=CC2=C1OC(C(O)=O)CO2 VBTYYGFMXUENNQ-UHFFFAOYSA-N 0.000 claims 1
- IUUUNZQSMODJAV-UHFFFAOYSA-N 5-[(4-octoxybenzoyl)amino]-3-(2h-tetrazol-5-yl)-2,3-dihydro-1,4-benzodioxine-6-carboxylic acid Chemical compound C1=CC(OCCCCCCCC)=CC=C1C(=O)NC1=C(OC(CO2)C=3NN=NN=3)C2=CC=C1C(O)=O IUUUNZQSMODJAV-UHFFFAOYSA-N 0.000 claims 1
- OMZOJDVVRPSXSI-UHFFFAOYSA-N 5-[3-(4-pentylphenyl)prop-2-enoylamino]-2,3-dihydro-1,4-benzodioxine-3-carboxylic acid Chemical compound C1=CC(CCCCC)=CC=C1C=CC(=O)NC1=CC=CC2=C1OC(C(O)=O)CO2 OMZOJDVVRPSXSI-UHFFFAOYSA-N 0.000 claims 1
- YJYCHCXKBSUYMX-UHFFFAOYSA-N 5-[3-(4-pentylphenyl)prop-2-enoylamino]-2-(2h-tetrazol-5-yl)-2,3-dihydro-1,4-benzodioxine-7-carboxylic acid Chemical compound C1=CC(CCCCC)=CC=C1C=CC(=O)NC1=CC(C(O)=O)=CC2=C1OCC(C1=NNN=N1)O2 YJYCHCXKBSUYMX-UHFFFAOYSA-N 0.000 claims 1
- NEJOAUBZXQIOMR-UHFFFAOYSA-N 5-[3-(4-pentylphenyl)prop-2-enoylamino]-2-(2h-tetrazol-5-yl)-2,3-dihydro-1,4-benzodioxine-8-carboxylic acid Chemical compound C1=CC(CCCCC)=CC=C1C=CC(=O)NC1=CC=C(C(O)=O)C2=C1OCC(C1=NNN=N1)O2 NEJOAUBZXQIOMR-UHFFFAOYSA-N 0.000 claims 1
- DPRRUYLJLBXQBZ-UHFFFAOYSA-N 5-[3-(4-pentylphenyl)prop-2-enoylamino]-3-(2h-tetrazol-5-yl)-2,3-dihydro-1,4-benzodioxine-7-carboxylic acid Chemical compound C1=CC(CCCCC)=CC=C1C=CC(=O)NC1=CC(C(O)=O)=CC2=C1OC(C1=NNN=N1)CO2 DPRRUYLJLBXQBZ-UHFFFAOYSA-N 0.000 claims 1
- MJGYWYPABCUGIY-UHFFFAOYSA-N 5-[3-(4-pentylphenyl)prop-2-enoylamino]-3-(2h-tetrazol-5-yl)-2,3-dihydro-1,4-benzodioxine-8-carboxylic acid Chemical compound C1=CC(CCCCC)=CC=C1C=CC(=O)NC1=CC=C(C(O)=O)C2=C1OC(C1=NNN=N1)CO2 MJGYWYPABCUGIY-UHFFFAOYSA-N 0.000 claims 1
- WUWRKHSSMRPABP-UHFFFAOYSA-N 6-[4-[3-oxo-3-[[3-(2h-tetrazol-5-yl)-2,3-dihydro-1,4-benzodioxin-5-yl]amino]prop-1-enyl]phenoxy]hexyl acetate Chemical compound C1=CC(OCCCCCCOC(=O)C)=CC=C1C=CC(=O)NC1=CC=CC2=C1OC(C1=NNN=N1)CO2 WUWRKHSSMRPABP-UHFFFAOYSA-N 0.000 claims 1
- BSQWIMCBLDXCDL-UHFFFAOYSA-N 6-methyl-4-oxo-8-[3-(4-pentylphenyl)prop-2-enoylamino]chromene-2-carboxylic acid Chemical compound C1=CC(CCCCC)=CC=C1C=CC(=O)NC1=CC(C)=CC2=C1OC(C(O)=O)=CC2=O BSQWIMCBLDXCDL-UHFFFAOYSA-N 0.000 claims 1
- JTUUBLKYIMEOKR-UHFFFAOYSA-N 8-[3-(4-oct-2-ynoxyphenyl)prop-2-enoylamino]-4-oxochromene-2-carboxylic acid Chemical compound C1=CC(OCC#CCCCCC)=CC=C1C=CC(=O)NC1=CC=CC2=C1OC(C(O)=O)=CC2=O JTUUBLKYIMEOKR-UHFFFAOYSA-N 0.000 claims 1
- MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 claims 1
- TUHZJOPWJMCXHZ-UHFFFAOYSA-N [3-amino-3-(2H-tetrazol-5-yl)-2H-1,4-benzodioxin-5-yl]-(4-heptylphenyl)methanethione Chemical compound C(CCCCCC)C1=CC=C(C(=S)C2=CC=CC3=C2OC(CO3)(C2=NN=NN2)N)C=C1 TUHZJOPWJMCXHZ-UHFFFAOYSA-N 0.000 claims 1
- 125000003647 acryloyl group Chemical group O=C([*])C([H])=C([H])[H] 0.000 claims 1
- 125000000816 ethylene group Chemical group [H]C([H])([*:1])C([H])([H])[*:2] 0.000 claims 1
- OPFQMORVVYKGSV-UHFFFAOYSA-N methyl 5-[(4-octoxybenzoyl)amino]-3-(2h-tetrazol-5-yl)-2,3-dihydro-1,4-benzodioxine-6-carboxylate Chemical compound C1=CC(OCCCCCCCC)=CC=C1C(=O)NC1=C(C(=O)OC)C=CC2=C1OC(C=1NN=NN=1)CO2 OPFQMORVVYKGSV-UHFFFAOYSA-N 0.000 claims 1
- VYNGOHMTMPJOEA-UHFFFAOYSA-N n-[3-(2h-tetrazol-5-yl)-2,3-dihydro-1,4-benzodioxin-5-yl]-4-undecylbenzamide Chemical compound C1=CC(CCCCCCCCCCC)=CC=C1C(=O)NC1=CC=CC2=C1OC(C=1NN=NN=1)CO2 VYNGOHMTMPJOEA-UHFFFAOYSA-N 0.000 claims 1
- MARYBSDPQQFQJS-UHFFFAOYSA-N n-[3-(2h-tetrazol-5-yl)-2,3-dihydro-1,4-benzodioxin-5-yl]naphthalene-2-carboxamide Chemical compound C=1C=C2C=CC=CC2=CC=1C(=O)NC(C=1O2)=CC=CC=1OCC2C1=NN=NN1 MARYBSDPQQFQJS-UHFFFAOYSA-N 0.000 claims 1
- YCBWXPZFTQJVPL-UHFFFAOYSA-N n-[4-oxo-2-(2h-tetrazol-5-yl)chromen-8-yl]-3-phenylprop-2-enamide Chemical compound C=1C=CC=CC=1C=CC(=O)NC1=CC=CC(C(C=2)=O)=C1OC=2C1=NN=NN1 YCBWXPZFTQJVPL-UHFFFAOYSA-N 0.000 claims 1
- XYJFBKXIVQEFIU-UHFFFAOYSA-N n-[4-oxo-2-(2h-tetrazol-5-yl)chromen-8-yl]-4-(4-thiophen-2-ylbutoxy)benzamide Chemical compound C=1C=C(OCCCCC=2SC=CC=2)C=CC=1C(=O)NC1=CC=CC(C(C=2)=O)=C1OC=2C=1N=NNN=1 XYJFBKXIVQEFIU-UHFFFAOYSA-N 0.000 claims 1
- UHEBOAKXRHMHMF-PJQLUOCWSA-N n-[4-oxo-2-(2h-tetrazol-5-yl)chromen-8-yl]-4-[(e)-3-phenylprop-1-enoxy]benzamide Chemical compound C=1C=C(O\C=C\CC=2C=CC=CC=2)C=CC=1C(=O)NC1=CC=CC(C(C=2)=O)=C1OC=2C=1N=NNN=1 UHEBOAKXRHMHMF-PJQLUOCWSA-N 0.000 claims 1
- ZNXFEDJVDQIABE-UHFFFAOYSA-N n-[6-methyl-4-oxo-2-(2h-tetrazol-5-yl)chromen-8-yl]-4-(4-thiophen-2-ylbutoxy)benzamide Chemical class C=12OC(C=3NN=NN=3)=CC(=O)C2=CC(C)=CC=1NC(=O)C(C=C1)=CC=C1OCCCCC1=CC=CS1 ZNXFEDJVDQIABE-UHFFFAOYSA-N 0.000 claims 1
- SUBWWPPJYPCVJL-MDWZMJQESA-N n-[6-methyl-4-oxo-2-(2h-tetrazol-5-yl)chromen-8-yl]-4-[(e)-oct-1-enoxy]benzamide Chemical compound C1=CC(O/C=C/CCCCCC)=CC=C1C(=O)NC1=CC(C)=CC2=C1OC(C1=NNN=N1)=CC2=O SUBWWPPJYPCVJL-MDWZMJQESA-N 0.000 claims 1
- YVOYCVJDUHQIHL-LZYBPNLTSA-N n-methyl-4-[(e)-oct-1-enoxy]-n-[3-(2h-tetrazol-5-yl)-2,3-dihydro-1,4-benzodioxin-5-yl]benzamide Chemical compound C1=CC(O/C=C/CCCCCC)=CC=C1C(=O)N(C)C1=CC=CC2=C1OC(C1=NNN=N1)CO2 YVOYCVJDUHQIHL-LZYBPNLTSA-N 0.000 claims 1
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 66
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 66
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 55
- 238000006243 chemical reaction Methods 0.000 description 27
- 238000000034 method Methods 0.000 description 27
- YZXBAPSDXZZRGB-DOFZRALJSA-N arachidonic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O YZXBAPSDXZZRGB-DOFZRALJSA-N 0.000 description 26
- 239000000243 solution Substances 0.000 description 26
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 24
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 17
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 17
- 239000002253 acid Substances 0.000 description 17
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 16
- 239000000203 mixture Substances 0.000 description 16
- 239000000126 substance Substances 0.000 description 16
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 16
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 15
- CTSLXHKWHWQRSH-UHFFFAOYSA-N oxalyl chloride Chemical compound ClC(=O)C(Cl)=O CTSLXHKWHWQRSH-UHFFFAOYSA-N 0.000 description 14
- 238000003786 synthesis reaction Methods 0.000 description 13
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 12
- 229940114079 arachidonic acid Drugs 0.000 description 12
- 235000021342 arachidonic acid Nutrition 0.000 description 12
- 230000000694 effects Effects 0.000 description 12
- 230000015572 biosynthetic process Effects 0.000 description 10
- 230000000704 physical effect Effects 0.000 description 10
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 10
- 229910001868 water Inorganic materials 0.000 description 10
- 239000003960 organic solvent Substances 0.000 description 9
- 239000000843 powder Substances 0.000 description 9
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 8
- 230000000172 allergic effect Effects 0.000 description 8
- 208000010668 atopic eczema Diseases 0.000 description 8
- 230000002401 inhibitory effect Effects 0.000 description 8
- 239000002904 solvent Substances 0.000 description 8
- 150000001412 amines Chemical class 0.000 description 7
- ZIIUUSVHCHPIQD-UHFFFAOYSA-N 2,4,6-trimethyl-N-[3-(trifluoromethyl)phenyl]benzenesulfonamide Chemical compound CC1=CC(C)=CC(C)=C1S(=O)(=O)NC1=CC=CC(C(F)(F)F)=C1 ZIIUUSVHCHPIQD-UHFFFAOYSA-N 0.000 description 6
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 6
- 108010066551 Cholestenone 5 alpha-Reductase Proteins 0.000 description 6
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 6
- 108010064785 Phospholipases Proteins 0.000 description 6
- 102000015439 Phospholipases Human genes 0.000 description 6
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 6
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 6
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 6
- 239000012300 argon atmosphere Substances 0.000 description 6
- 201000010099 disease Diseases 0.000 description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 6
- 230000037361 pathway Effects 0.000 description 6
- 208000019693 Lung disease Diseases 0.000 description 5
- 241000124008 Mammalia Species 0.000 description 5
- 239000013543 active substance Substances 0.000 description 5
- 150000001350 alkyl halides Chemical class 0.000 description 5
- 208000026935 allergic disease Diseases 0.000 description 5
- 208000006673 asthma Diseases 0.000 description 5
- 239000003814 drug Substances 0.000 description 5
- 150000004820 halides Chemical class 0.000 description 5
- 230000000144 pharmacologic effect Effects 0.000 description 5
- 229910000027 potassium carbonate Inorganic materials 0.000 description 5
- 235000011181 potassium carbonates Nutrition 0.000 description 5
- 150000003180 prostaglandins Chemical class 0.000 description 5
- 238000010898 silica gel chromatography Methods 0.000 description 5
- 238000003756 stirring Methods 0.000 description 5
- NNDIXBJHNLFJJP-UHFFFAOYSA-N 20-Hydroxyeicosatetraenoic acid Chemical compound OCCCCCC=CCC=CCC=CCC=CCCCC(O)=O NNDIXBJHNLFJJP-UHFFFAOYSA-N 0.000 description 4
- MGBKJKDRMRAZKC-UHFFFAOYSA-N 3-aminobenzene-1,2-diol Chemical compound NC1=CC=CC(O)=C1O MGBKJKDRMRAZKC-UHFFFAOYSA-N 0.000 description 4
- 102000016912 Aldehyde Reductase Human genes 0.000 description 4
- 108010053754 Aldehyde reductase Proteins 0.000 description 4
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- 102000004190 Enzymes Human genes 0.000 description 4
- 108090000790 Enzymes Proteins 0.000 description 4
- 206010020751 Hypersensitivity Diseases 0.000 description 4
- 206010061218 Inflammation Diseases 0.000 description 4
- PXIPVTKHYLBLMZ-UHFFFAOYSA-N Sodium azide Chemical compound [Na+].[N-]=[N+]=[N-] PXIPVTKHYLBLMZ-UHFFFAOYSA-N 0.000 description 4
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 4
- 208000007536 Thrombosis Diseases 0.000 description 4
- 239000007864 aqueous solution Substances 0.000 description 4
- 230000008602 contraction Effects 0.000 description 4
- 239000013078 crystal Substances 0.000 description 4
- 150000002430 hydrocarbons Chemical group 0.000 description 4
- 239000003701 inert diluent Substances 0.000 description 4
- 230000004054 inflammatory process Effects 0.000 description 4
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 4
- 229940094443 oxytocics prostaglandins Drugs 0.000 description 4
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 4
- 238000010992 reflux Methods 0.000 description 4
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical class O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 4
- 125000001424 substituent group Chemical group 0.000 description 4
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 4
- NVKAWKQGWWIWPM-ABEVXSGRSA-N 17-β-hydroxy-5-α-Androstan-3-one Chemical compound C1C(=O)CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CC[C@H]21 NVKAWKQGWWIWPM-ABEVXSGRSA-N 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 208000002874 Acne Vulgaris Diseases 0.000 description 3
- 201000004384 Alopecia Diseases 0.000 description 3
- 206010004446 Benign prostatic hyperplasia Diseases 0.000 description 3
- 208000014181 Bronchial disease Diseases 0.000 description 3
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 3
- 102000003820 Lipoxygenases Human genes 0.000 description 3
- 108090000128 Lipoxygenases Proteins 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 208000004403 Prostatic Hyperplasia Diseases 0.000 description 3
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- DHKHKXVYLBGOIT-UHFFFAOYSA-N acetaldehyde Diethyl Acetal Natural products CCOC(C)OCC DHKHKXVYLBGOIT-UHFFFAOYSA-N 0.000 description 3
- 150000001241 acetals Chemical class 0.000 description 3
- 150000008065 acid anhydrides Chemical class 0.000 description 3
- 206010000496 acne Diseases 0.000 description 3
- 230000009471 action Effects 0.000 description 3
- 125000005108 alkenylthio group Chemical group 0.000 description 3
- 125000005109 alkynylthio group Chemical group 0.000 description 3
- 230000007815 allergy Effects 0.000 description 3
- 231100000360 alopecia Toxicity 0.000 description 3
- 230000003042 antagnostic effect Effects 0.000 description 3
- 238000001816 cooling Methods 0.000 description 3
- 239000007924 injection Substances 0.000 description 3
- 238000002347 injection Methods 0.000 description 3
- 239000000543 intermediate Substances 0.000 description 3
- 239000000314 lubricant Substances 0.000 description 3
- 210000004072 lung Anatomy 0.000 description 3
- 239000011259 mixed solution Substances 0.000 description 3
- 239000012046 mixed solvent Substances 0.000 description 3
- 125000001147 pentyl group Chemical group C(CCCC)* 0.000 description 3
- 230000002265 prevention Effects 0.000 description 3
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 3
- 235000017557 sodium bicarbonate Nutrition 0.000 description 3
- 229910000029 sodium carbonate Inorganic materials 0.000 description 3
- 235000017550 sodium carbonate Nutrition 0.000 description 3
- 239000008247 solid mixture Substances 0.000 description 3
- 238000004809 thin layer chromatography Methods 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- DCIDQCMMRAKNNR-UHFFFAOYSA-N 1,4-benzodithiine Chemical group C1=CC=C2SC=CSC2=C1 DCIDQCMMRAKNNR-UHFFFAOYSA-N 0.000 description 2
- VIDHILKLKOQXEB-UHFFFAOYSA-N 2,3-dihydro-1,4-benzodithiine Chemical compound C1=CC=C2SCCSC2=C1 VIDHILKLKOQXEB-UHFFFAOYSA-N 0.000 description 2
- CWJSCIWGSUCULS-UHFFFAOYSA-N 2-hydroperoxyicosa-2,4,6,8-tetraenoic acid Chemical compound CCCCCCCCCCCC=CC=CC=CC=C(OO)C(O)=O CWJSCIWGSUCULS-UHFFFAOYSA-N 0.000 description 2
- YYROPELSRYBVMQ-UHFFFAOYSA-N 4-toluenesulfonyl chloride Chemical compound CC1=CC=C(S(Cl)(=O)=O)C=C1 YYROPELSRYBVMQ-UHFFFAOYSA-N 0.000 description 2
- JNUUNUQHXIOFDA-XTDASVJISA-N 5-HPETE Chemical compound CCCCC\C=C/C\C=C/C\C=C/C=C/C(OO)CCCC(O)=O JNUUNUQHXIOFDA-XTDASVJISA-N 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 2
- 206010002198 Anaphylactic reaction Diseases 0.000 description 2
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- 206010007749 Cataract diabetic Diseases 0.000 description 2
- 241000700198 Cavia Species 0.000 description 2
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 2
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 2
- OKKJLVBELUTLKV-MZCSYVLQSA-N Deuterated methanol Chemical compound [2H]OC([2H])([2H])[2H] OKKJLVBELUTLKV-MZCSYVLQSA-N 0.000 description 2
- 208000002249 Diabetes Complications Diseases 0.000 description 2
- 206010012655 Diabetic complications Diseases 0.000 description 2
- ROSDSFDQCJNGOL-UHFFFAOYSA-N Dimethylamine Chemical compound CNC ROSDSFDQCJNGOL-UHFFFAOYSA-N 0.000 description 2
- 108010010803 Gelatin Proteins 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 description 2
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 2
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 2
- 102000005398 Monoacylglycerol Lipase Human genes 0.000 description 2
- 108020002334 Monoacylglycerol lipase Proteins 0.000 description 2
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 2
- 102000004005 Prostaglandin-endoperoxide synthases Human genes 0.000 description 2
- 108090000459 Prostaglandin-endoperoxide synthases Proteins 0.000 description 2
- 241000700159 Rattus Species 0.000 description 2
- 208000017442 Retinal disease Diseases 0.000 description 2
- 206010038923 Retinopathy Diseases 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- MUMGGOZAMZWBJJ-DYKIIFRCSA-N Testostosterone Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 MUMGGOZAMZWBJJ-DYKIIFRCSA-N 0.000 description 2
- 208000027515 Tracheal disease Diseases 0.000 description 2
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 2
- 102000014384 Type C Phospholipases Human genes 0.000 description 2
- 108010079194 Type C Phospholipases Proteins 0.000 description 2
- 238000000862 absorption spectrum Methods 0.000 description 2
- WEVYAHXRMPXWCK-UHFFFAOYSA-N acetonitrile Substances CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 2
- 150000007513 acids Chemical class 0.000 description 2
- 150000001323 aldoses Chemical class 0.000 description 2
- 230000036783 anaphylactic response Effects 0.000 description 2
- 208000003455 anaphylaxis Diseases 0.000 description 2
- 239000000427 antigen Substances 0.000 description 2
- 102000036639 antigens Human genes 0.000 description 2
- 108091007433 antigens Proteins 0.000 description 2
- 239000007900 aqueous suspension Substances 0.000 description 2
- 206010003246 arthritis Diseases 0.000 description 2
- 239000012298 atmosphere Substances 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 239000002585 base Substances 0.000 description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
- 210000004556 brain Anatomy 0.000 description 2
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 229960005069 calcium Drugs 0.000 description 2
- 150000001721 carbon Chemical group 0.000 description 2
- YCIMNLLNPGFGHC-UHFFFAOYSA-N catechol Chemical compound OC1=CC=CC=C1O YCIMNLLNPGFGHC-UHFFFAOYSA-N 0.000 description 2
- 150000001768 cations Chemical class 0.000 description 2
- 230000004663 cell proliferation Effects 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 239000002642 cobra venom Substances 0.000 description 2
- 210000004351 coronary vessel Anatomy 0.000 description 2
- 201000007025 diabetic cataract Diseases 0.000 description 2
- 239000007884 disintegrant Substances 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003995 emulsifying agent Substances 0.000 description 2
- 210000003038 endothelium Anatomy 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- FBPFZTCFMRRESA-GUCUJZIJSA-N galactitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-GUCUJZIJSA-N 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 239000008273 gelatin Substances 0.000 description 2
- 229920000159 gelatin Polymers 0.000 description 2
- 235000019322 gelatine Nutrition 0.000 description 2
- 235000011852 gelatine desserts Nutrition 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 2
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 2
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 2
- 210000003405 ileum Anatomy 0.000 description 2
- 230000008105 immune reaction Effects 0.000 description 2
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- VNYSSYRCGWBHLG-AMOLWHMGSA-N leukotriene B4 Chemical compound CCCCC\C=C/C[C@@H](O)\C=C\C=C\C=C/[C@@H](O)CCCC(O)=O VNYSSYRCGWBHLG-AMOLWHMGSA-N 0.000 description 2
- 239000011777 magnesium Substances 0.000 description 2
- 229910052749 magnesium Inorganic materials 0.000 description 2
- 235000019359 magnesium stearate Nutrition 0.000 description 2
- 230000037353 metabolic pathway Effects 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 2
- 239000008108 microcrystalline cellulose Substances 0.000 description 2
- 229940016286 microcrystalline cellulose Drugs 0.000 description 2
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 230000007823 neuropathy Effects 0.000 description 2
- 239000012457 nonaqueous media Substances 0.000 description 2
- 238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 2
- 238000007911 parenteral administration Methods 0.000 description 2
- WTJKGGKOPKCXLL-RRHRGVEJSA-N phosphatidylcholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCC=CCCCCCCCC WTJKGGKOPKCXLL-RRHRGVEJSA-N 0.000 description 2
- 150000003905 phosphatidylinositols Chemical class 0.000 description 2
- 150000003904 phospholipids Chemical class 0.000 description 2
- 229920005862 polyol Polymers 0.000 description 2
- 150000003077 polyols Chemical class 0.000 description 2
- 229910052700 potassium Inorganic materials 0.000 description 2
- 239000011591 potassium Substances 0.000 description 2
- 229960003975 potassium Drugs 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- YIBNHAJFJUQSRA-YNNPMVKQSA-N prostaglandin H2 Chemical compound C1[C@@H]2OO[C@H]1[C@H](/C=C/[C@@H](O)CCCCC)[C@H]2C\C=C/CCCC(O)=O YIBNHAJFJUQSRA-YNNPMVKQSA-N 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 239000011541 reaction mixture Substances 0.000 description 2
- 239000000741 silica gel Substances 0.000 description 2
- 229910002027 silica gel Inorganic materials 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 239000000600 sorbitol Substances 0.000 description 2
- 239000007858 starting material Substances 0.000 description 2
- 125000000446 sulfanediyl group Chemical group *S* 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 150000003512 tertiary amines Chemical class 0.000 description 2
- DSNBHJFQCNUKMA-SCKDECHMSA-N thromboxane A2 Chemical compound OC(=O)CCC\C=C/C[C@@H]1[C@@H](/C=C/[C@@H](O)CCCCC)O[C@@H]2O[C@H]1C2 DSNBHJFQCNUKMA-SCKDECHMSA-N 0.000 description 2
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 2
- QAEDZJGFFMLHHQ-UHFFFAOYSA-N trifluoroacetic anhydride Chemical compound FC(F)(F)C(=O)OC(=O)C(F)(F)F QAEDZJGFFMLHHQ-UHFFFAOYSA-N 0.000 description 2
- 239000003039 volatile agent Substances 0.000 description 2
- PXGPLTODNUVGFL-BRIYLRKRSA-N (E,Z)-(1R,2R,3R,5S)-7-(3,5-Dihydroxy-2-((3S)-(3-hydroxy-1-octenyl))cyclopentyl)-5-heptenoic acid Chemical compound CCCCC[C@H](O)C=C[C@H]1[C@H](O)C[C@H](O)[C@@H]1CC=CCCCC(O)=O PXGPLTODNUVGFL-BRIYLRKRSA-N 0.000 description 1
- WBYWAXJHAXSJNI-VOTSOKGWSA-M .beta-Phenylacrylic acid Natural products [O-]C(=O)\C=C\C1=CC=CC=C1 WBYWAXJHAXSJNI-VOTSOKGWSA-M 0.000 description 1
- AYBMNNVJIQJYBR-UHFFFAOYSA-N 1-(6-amino-2,3-dihydroxyphenyl)-3-(3-methoxy-4-pentoxyphenyl)prop-2-en-1-one Chemical compound C1=C(OC)C(OCCCCC)=CC=C1C=CC(=O)C1=C(N)C=CC(O)=C1O AYBMNNVJIQJYBR-UHFFFAOYSA-N 0.000 description 1
- ZIOZYRSDNLNNNJ-LQWMCKPYSA-N 12(S)-HPETE Chemical compound CCCCC\C=C/C[C@H](OO)\C=C\C=C/C\C=C/CCCC(O)=O ZIOZYRSDNLNNNJ-LQWMCKPYSA-N 0.000 description 1
- ZNHVWPKMFKADKW-UHFFFAOYSA-N 12-HETE Chemical compound CCCCCC=CCC(O)C=CC=CCC=CCCCC(O)=O ZNHVWPKMFKADKW-UHFFFAOYSA-N 0.000 description 1
- ZNHVWPKMFKADKW-ZYBDYUKJSA-N 12-HETE Natural products CCCCC\C=C/C[C@@H](O)\C=C\C=C/C\C=C/CCCC(O)=O ZNHVWPKMFKADKW-ZYBDYUKJSA-N 0.000 description 1
- BFWYTORDSFIVKP-VAEKSGALSA-N 15(S)-HPETE Chemical compound CCCCC[C@H](OO)\C=C\C=C/C\C=C/C\C=C/CCCC(O)=O BFWYTORDSFIVKP-VAEKSGALSA-N 0.000 description 1
- JSFATNQSLKRBCI-VAEKSGALSA-N 15-HETE Natural products CCCCC[C@H](O)\C=C\C=C/C\C=C/C\C=C/CCCC(O)=O JSFATNQSLKRBCI-VAEKSGALSA-N 0.000 description 1
- BFWYTORDSFIVKP-USWFWKISSA-N 15-HPETE Chemical compound CCCCCC(OO)\C=C\C=C/C\C=C/C\C=C/CCCC(O)=O BFWYTORDSFIVKP-USWFWKISSA-N 0.000 description 1
- JSFATNQSLKRBCI-UHFFFAOYSA-N 15-Hydroxyeicosatetraenoic acid Chemical compound CCCCCC(O)C=CC=CCC=CCC=CCCCC(O)=O JSFATNQSLKRBCI-UHFFFAOYSA-N 0.000 description 1
- JVSFQJZRHXAUGT-UHFFFAOYSA-N 2,2-dimethylpropanoyl chloride Chemical compound CC(C)(C)C(Cl)=O JVSFQJZRHXAUGT-UHFFFAOYSA-N 0.000 description 1
- WSKHWVDWCPYUAB-UHFFFAOYSA-N 2,3-dihydro-1,4-benzodioxine;hydrochloride Chemical compound Cl.C1=CC=C2OCCOC2=C1 WSKHWVDWCPYUAB-UHFFFAOYSA-N 0.000 description 1
- ZHRFVYGXXJVFCG-UHFFFAOYSA-N 2,3-dihydro-1,4-benzodioxine;sodium Chemical compound [Na].C1=CC=C2OCCOC2=C1 ZHRFVYGXXJVFCG-UHFFFAOYSA-N 0.000 description 1
- OYUNTGBISCIYPW-UHFFFAOYSA-N 2-chloroprop-2-enenitrile Chemical compound ClC(=C)C#N OYUNTGBISCIYPW-UHFFFAOYSA-N 0.000 description 1
- BSKHPKMHTQYZBB-UHFFFAOYSA-N 2-methylpyridine Chemical compound CC1=CC=CC=N1 BSKHPKMHTQYZBB-UHFFFAOYSA-N 0.000 description 1
- OUTKAEVCBLAWDO-UHFFFAOYSA-N 2h-chromene;hydrochloride Chemical compound Cl.C1=CC=C2C=CCOC2=C1 OUTKAEVCBLAWDO-UHFFFAOYSA-N 0.000 description 1
- UBIPKJBLXYYVAX-UHFFFAOYSA-N 3-(2h-tetrazol-5-yl)-2,3-dihydro-1,4-benzodithiin-5-amine;hydrochloride Chemical compound Cl.S1C=2C(N)=CC=CC=2SCC1C1=NN=NN1 UBIPKJBLXYYVAX-UHFFFAOYSA-N 0.000 description 1
- LZUMEVGHGKCPJK-UHFFFAOYSA-N 3-(4-pentylphenyl)prop-2-enoic acid Chemical compound CCCCCC1=CC=C(C=CC(O)=O)C=C1 LZUMEVGHGKCPJK-UHFFFAOYSA-N 0.000 description 1
- HJXPTUVILZSZGP-UHFFFAOYSA-N 3-[4-(5-bromopentoxy)phenyl]-n-(2,3-dihydro-1,4-benzodioxin-5-yl)prop-2-enamide Chemical compound C1=CC(OCCCCCBr)=CC=C1C=CC(=O)NC1=CC=CC2=C1OCCO2 HJXPTUVILZSZGP-UHFFFAOYSA-N 0.000 description 1
- HVTHYMNEWWNSKM-UHFFFAOYSA-N 3-methoxy-4-pentoxybenzoic acid Chemical compound CCCCCOC1=CC=C(C(O)=O)C=C1OC HVTHYMNEWWNSKM-UHFFFAOYSA-N 0.000 description 1
- KGIJOOYOSFUGPC-CABOLEKPSA-N 5-HETE Natural products CCCCC\C=C/C\C=C/C\C=C/C=C/[C@H](O)CCCC(O)=O KGIJOOYOSFUGPC-CABOLEKPSA-N 0.000 description 1
- KGIJOOYOSFUGPC-MSFIICATSA-N 5-Hydroxyeicosatetraenoic acid Chemical compound CCCCCC=CCC=CCC=C\C=C\[C@@H](O)CCCC(O)=O KGIJOOYOSFUGPC-MSFIICATSA-N 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 206010002199 Anaphylactic shock Diseases 0.000 description 1
- 102000011730 Arachidonate 12-Lipoxygenase Human genes 0.000 description 1
- 108010076676 Arachidonate 12-lipoxygenase Proteins 0.000 description 1
- 102000009515 Arachidonate 15-Lipoxygenase Human genes 0.000 description 1
- 108010048907 Arachidonate 15-lipoxygenase Proteins 0.000 description 1
- 102000001381 Arachidonate 5-Lipoxygenase Human genes 0.000 description 1
- 108010093579 Arachidonate 5-lipoxygenase Proteins 0.000 description 1
- WPYMKLBDIGXBTP-UHFFFAOYSA-N Benzoic acid Natural products OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
- 239000004215 Carbon black (E152) Substances 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- 241000700199 Cavia porcellus Species 0.000 description 1
- 241000282693 Cercopithecidae Species 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- 241000252095 Congridae Species 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- RGHNJXZEOKUKBD-SQOUGZDYSA-N D-gluconic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 description 1
- GSNUFIFRDBKVIE-UHFFFAOYSA-N DMF Natural products CC1=CC=C(C)O1 GSNUFIFRDBKVIE-UHFFFAOYSA-N 0.000 description 1
- 208000032131 Diabetic Neuropathies Diseases 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- 102000009123 Fibrin Human genes 0.000 description 1
- 108010073385 Fibrin Proteins 0.000 description 1
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 description 1
- 208000027472 Galactosemias Diseases 0.000 description 1
- 101710107035 Gamma-glutamyltranspeptidase Proteins 0.000 description 1
- 101710173228 Glutathione hydrolase proenzyme Proteins 0.000 description 1
- 201000005569 Gout Diseases 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical group OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical class NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 102000017055 Lipoprotein Lipase Human genes 0.000 description 1
- 108010013563 Lipoprotein Lipase Proteins 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 239000012359 Methanesulfonyl chloride Substances 0.000 description 1
- SECXISVLQFMRJM-UHFFFAOYSA-N N-Methylpyrrolidone Chemical compound CN1CCCC1=O SECXISVLQFMRJM-UHFFFAOYSA-N 0.000 description 1
- 102000003992 Peroxidases Human genes 0.000 description 1
- QPFYXYFORQJZEC-FOCLMDBBSA-N Phenazopyridine Chemical compound NC1=NC(N)=CC=C1\N=N\C1=CC=CC=C1 QPFYXYFORQJZEC-FOCLMDBBSA-N 0.000 description 1
- BHHGXPLMPWCGHP-UHFFFAOYSA-N Phenethylamine Chemical class NCCC1=CC=CC=C1 BHHGXPLMPWCGHP-UHFFFAOYSA-N 0.000 description 1
- 229940124154 Phospholipase inhibitor Drugs 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 206010047139 Vasoconstriction Diseases 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 125000002252 acyl group Chemical group 0.000 description 1
- 125000004442 acylamino group Chemical group 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 229910000272 alkali metal oxide Inorganic materials 0.000 description 1
- 150000001340 alkali metals Chemical class 0.000 description 1
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 1
- 229910001860 alkaline earth metal hydroxide Inorganic materials 0.000 description 1
- 125000005193 alkenylcarbonyloxy group Chemical group 0.000 description 1
- 125000005452 alkenyloxyalkyl group Chemical group 0.000 description 1
- 125000000278 alkyl amino alkyl group Chemical group 0.000 description 1
- 125000003282 alkyl amino group Chemical group 0.000 description 1
- 125000004448 alkyl carbonyl group Chemical group 0.000 description 1
- 125000002947 alkylene group Chemical group 0.000 description 1
- 125000004419 alkynylene group Chemical group 0.000 description 1
- 230000009285 allergic inflammation Effects 0.000 description 1
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 235000010210 aluminium Nutrition 0.000 description 1
- 125000002431 aminoalkoxy group Chemical group 0.000 description 1
- 125000004103 aminoalkyl group Chemical group 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 235000019270 ammonium chloride Nutrition 0.000 description 1
- 150000003863 ammonium salts Chemical class 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 229960003473 androstanolone Drugs 0.000 description 1
- 230000008485 antagonism Effects 0.000 description 1
- 229940125715 antihistaminic agent Drugs 0.000 description 1
- 239000000739 antihistaminic agent Substances 0.000 description 1
- 125000001204 arachidyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000000637 arginyl group Chemical class N[C@@H](CCCNC(N)=N)C(=O)* 0.000 description 1
- 229910052786 argon Inorganic materials 0.000 description 1
- 125000004429 atom Chemical group 0.000 description 1
- 239000012752 auxiliary agent Substances 0.000 description 1
- 125000005335 azido alkyl group Chemical group 0.000 description 1
- WXBLLCUINBKULX-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1.OC(=O)C1=CC=CC=C1 WXBLLCUINBKULX-UHFFFAOYSA-N 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- 150000003939 benzylamines Chemical class 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 1
- 229910052794 bromium Inorganic materials 0.000 description 1
- 239000004044 bronchoconstricting agent Substances 0.000 description 1
- 230000003435 bronchoconstrictive effect Effects 0.000 description 1
- 239000004227 calcium gluconate Substances 0.000 description 1
- 235000013927 calcium gluconate Nutrition 0.000 description 1
- 229960004494 calcium gluconate Drugs 0.000 description 1
- 239000003710 calcium ionophore Substances 0.000 description 1
- BRPQOXSCLDDYGP-UHFFFAOYSA-N calcium oxide Chemical compound [O-2].[Ca+2] BRPQOXSCLDDYGP-UHFFFAOYSA-N 0.000 description 1
- 239000000292 calcium oxide Substances 0.000 description 1
- ODINCKMPIJJUCX-UHFFFAOYSA-N calcium oxide Inorganic materials [Ca]=O ODINCKMPIJJUCX-UHFFFAOYSA-N 0.000 description 1
- 235000012255 calcium oxide Nutrition 0.000 description 1
- NEEHYRZPVYRGPP-UHFFFAOYSA-L calcium;2,3,4,5,6-pentahydroxyhexanoate Chemical compound [Ca+2].OCC(O)C(O)C(O)C(O)C([O-])=O.OCC(O)C(O)C(O)C(O)C([O-])=O NEEHYRZPVYRGPP-UHFFFAOYSA-L 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 239000011203 carbon fibre reinforced carbon Substances 0.000 description 1
- 125000006297 carbonyl amino group Chemical group [H]N([*:2])C([*:1])=O 0.000 description 1
- 150000001735 carboxylic acids Chemical class 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 235000010980 cellulose Nutrition 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- FZFAMSAMCHXGEF-UHFFFAOYSA-N chloro formate Chemical compound ClOC=O FZFAMSAMCHXGEF-UHFFFAOYSA-N 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- 238000013375 chromatographic separation Methods 0.000 description 1
- 229930016911 cinnamic acid Natural products 0.000 description 1
- 235000013985 cinnamic acid Nutrition 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 210000000695 crystalline len Anatomy 0.000 description 1
- 125000004093 cyano group Chemical group *C#N 0.000 description 1
- 125000000000 cycloalkoxy group Chemical group 0.000 description 1
- 125000005366 cycloalkylthio group Chemical group 0.000 description 1
- NISGSNTVMOOSJQ-UHFFFAOYSA-N cyclopentanamine Chemical class NC1CCCC1 NISGSNTVMOOSJQ-UHFFFAOYSA-N 0.000 description 1
- 125000002704 decyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 239000000645 desinfectant Substances 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 125000004985 dialkyl amino alkyl group Chemical group 0.000 description 1
- ZBCBWPMODOFKDW-UHFFFAOYSA-N diethanolamine Chemical class OCCNCCO ZBCBWPMODOFKDW-UHFFFAOYSA-N 0.000 description 1
- WOAZEKPXTXCPFZ-UHFFFAOYSA-N dimethyl(phenyl)azanium;chloride Chemical compound Cl.CN(C)C1=CC=CC=C1 WOAZEKPXTXCPFZ-UHFFFAOYSA-N 0.000 description 1
- 150000004656 dimethylamines Chemical class 0.000 description 1
- XEYBRNLFEZDVAW-ARSRFYASSA-N dinoprostone Chemical compound CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1C\C=C/CCCC(O)=O XEYBRNLFEZDVAW-ARSRFYASSA-N 0.000 description 1
- 239000002270 dispersing agent Substances 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 125000003438 dodecyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 235000013345 egg yolk Nutrition 0.000 description 1
- 210000002969 egg yolk Anatomy 0.000 description 1
- 239000012156 elution solvent Substances 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 210000002472 endoplasmic reticulum Anatomy 0.000 description 1
- KAQKFAOMNZTLHT-VVUHWYTRSA-N epoprostenol Chemical compound O1C(=CCCCC(O)=O)C[C@@H]2[C@@H](/C=C/[C@@H](O)CCCCC)[C@H](O)C[C@@H]21 KAQKFAOMNZTLHT-VVUHWYTRSA-N 0.000 description 1
- 229960001123 epoprostenol Drugs 0.000 description 1
- AQTVKHUZORYGPE-UHFFFAOYSA-N ethanol;ethyl acetate;methanol Chemical compound OC.CCO.CCOC(C)=O AQTVKHUZORYGPE-UHFFFAOYSA-N 0.000 description 1
- 150000002169 ethanolamines Chemical class 0.000 description 1
- CJAONIOAQZUHPN-KKLWWLSJSA-N ethyl 12-[[2-[(2r,3r)-3-[2-[(12-ethoxy-12-oxododecyl)-methylamino]-2-oxoethoxy]butan-2-yl]oxyacetyl]-methylamino]dodecanoate Chemical compound CCOC(=O)CCCCCCCCCCCN(C)C(=O)CO[C@H](C)[C@@H](C)OCC(=O)N(C)CCCCCCCCCCCC(=O)OCC CJAONIOAQZUHPN-KKLWWLSJSA-N 0.000 description 1
- CJVFJZNWXDFXHF-UHFFFAOYSA-N ethyl 4-oxochromene-2-carboxylate Chemical compound C1=CC=C2OC(C(=O)OCC)=CC(=O)C2=C1 CJVFJZNWXDFXHF-UHFFFAOYSA-N 0.000 description 1
- KYZBIYDKNADGMT-UHFFFAOYSA-N ethyl 4h-chromene-2-carboxylate Chemical compound C1=CC=C2OC(C(=O)OCC)=CCC2=C1 KYZBIYDKNADGMT-UHFFFAOYSA-N 0.000 description 1
- OAYLNYINCPYISS-UHFFFAOYSA-N ethyl acetate;hexane Chemical compound CCCCCC.CCOC(C)=O OAYLNYINCPYISS-UHFFFAOYSA-N 0.000 description 1
- RIFGWPKJUGCATF-UHFFFAOYSA-N ethyl chloroformate Chemical compound CCOC(Cl)=O RIFGWPKJUGCATF-UHFFFAOYSA-N 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 229950003499 fibrin Drugs 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 125000001153 fluoro group Chemical group F* 0.000 description 1
- 235000013355 food flavoring agent Nutrition 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 229930182830 galactose Natural products 0.000 description 1
- 102000006640 gamma-Glutamyltransferase Human genes 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 235000001727 glucose Nutrition 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 125000003187 heptyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 229960001340 histamine Drugs 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 description 1
- 229910000041 hydrogen chloride Inorganic materials 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- 125000002768 hydroxyalkyl group Chemical group 0.000 description 1
- 229920003132 hydroxypropyl methylcellulose phthalate Polymers 0.000 description 1
- 229940031704 hydroxypropyl methylcellulose phthalate Drugs 0.000 description 1
- 239000005457 ice water Substances 0.000 description 1
- 125000005462 imide group Chemical group 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 239000011261 inert gas Substances 0.000 description 1
- 208000030603 inherited susceptibility to asthma Diseases 0.000 description 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
- 208000017169 kidney disease Diseases 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 239000003199 leukotriene receptor blocking agent Substances 0.000 description 1
- 239000000865 liniment Substances 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 229910052744 lithium Inorganic materials 0.000 description 1
- GUWHRJQTTVADPB-UHFFFAOYSA-N lithium azide Chemical compound [Li+].[N-]=[N+]=[N-] GUWHRJQTTVADPB-UHFFFAOYSA-N 0.000 description 1
- FUJCRWPEOMXPAD-UHFFFAOYSA-N lithium oxide Chemical compound [Li+].[Li+].[O-2] FUJCRWPEOMXPAD-UHFFFAOYSA-N 0.000 description 1
- 229910001947 lithium oxide Inorganic materials 0.000 description 1
- HCWCAKKEBCNQJP-UHFFFAOYSA-N magnesium orthosilicate Chemical compound [Mg+2].[Mg+2].[O-][Si]([O-])([O-])[O-] HCWCAKKEBCNQJP-UHFFFAOYSA-N 0.000 description 1
- 239000000391 magnesium silicate Substances 0.000 description 1
- 229910052919 magnesium silicate Inorganic materials 0.000 description 1
- 235000019792 magnesium silicate Nutrition 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 125000002960 margaryl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 238000004949 mass spectrometry Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 229940127554 medical product Drugs 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- UKVIEHSSVKSQBA-UHFFFAOYSA-N methane;palladium Chemical compound C.[Pd] UKVIEHSSVKSQBA-UHFFFAOYSA-N 0.000 description 1
- QARBMVPHQWIHKH-UHFFFAOYSA-N methanesulfonyl chloride Chemical compound CS(Cl)(=O)=O QARBMVPHQWIHKH-UHFFFAOYSA-N 0.000 description 1
- RWIKCBHOVNDESJ-NSCUHMNNSA-N methyl (e)-4-bromobut-2-enoate Chemical compound COC(=O)\C=C\CBr RWIKCBHOVNDESJ-NSCUHMNNSA-N 0.000 description 1
- IBXXLOVERQZZPD-UHFFFAOYSA-N methyl 2-[5-[3-(4-pentylphenyl)prop-2-enoylamino]-2,3-dihydro-1,4-benzodioxin-3-yl]acetate Chemical compound C1=CC(CCCCC)=CC=C1C=CC(=O)NC1=CC=CC2=C1OC(CC(=O)OC)CO2 IBXXLOVERQZZPD-UHFFFAOYSA-N 0.000 description 1
- WBYWAXJHAXSJNI-UHFFFAOYSA-N methyl p-hydroxycinnamate Natural products OC(=O)C=CC1=CC=CC=C1 WBYWAXJHAXSJNI-UHFFFAOYSA-N 0.000 description 1
- 150000003956 methylamines Chemical class 0.000 description 1
- 230000005012 migration Effects 0.000 description 1
- 238000013508 migration Methods 0.000 description 1
- 125000001421 myristyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- VAKHKENKNZYEBL-UHFFFAOYSA-N n-(2,3-dihydroxyphenyl)-3-(3-methoxy-4-pentoxyphenyl)prop-2-enamide Chemical compound C1=C(OC)C(OCCCCC)=CC=C1C=CC(=O)NC1=CC=CC(O)=C1O VAKHKENKNZYEBL-UHFFFAOYSA-N 0.000 description 1
- PVZATXIEOIUQHW-UHFFFAOYSA-N n-(2,3-dihydroxyphenyl)-3-(4-pentylphenyl)prop-2-enamide Chemical compound C1=CC(CCCCC)=CC=C1C=CC(=O)NC1=CC=CC(O)=C1O PVZATXIEOIUQHW-UHFFFAOYSA-N 0.000 description 1
- PQQHWKNBLCKGTR-UHFFFAOYSA-N n-[3-(2-amino-2-oxoethyl)-2,3-dihydro-1,4-benzodioxin-5-yl]-3-(4-pentylphenyl)prop-2-enamide Chemical compound C1=CC(CCCCC)=CC=C1C=CC(=O)NC1=CC=CC2=C1OC(CC(N)=O)CO2 PQQHWKNBLCKGTR-UHFFFAOYSA-N 0.000 description 1
- 201000001119 neuropathy Diseases 0.000 description 1
- 125000001196 nonadecyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000001400 nonyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 125000002347 octyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 125000005429 oxyalkyl group Chemical group 0.000 description 1
- 125000000913 palmityl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000002958 pentadecyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000004115 pentoxy group Chemical group [*]OC([H])([H])C([H])([H])C([H])([H])C(C([H])([H])[H])([H])[H] 0.000 description 1
- 210000000578 peripheral nerve Anatomy 0.000 description 1
- 208000033808 peripheral neuropathy Diseases 0.000 description 1
- 108040007629 peroxidase activity proteins Proteins 0.000 description 1
- 239000003428 phospholipase inhibitor Substances 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 150000003053 piperidines Chemical class 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 239000000244 polyoxyethylene sorbitan monooleate Substances 0.000 description 1
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 1
- 229940068968 polysorbate 80 Drugs 0.000 description 1
- 229920000053 polysorbate 80 Polymers 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- TZLVRPLSVNESQC-UHFFFAOYSA-N potassium azide Chemical compound [K+].[N-]=[N+]=[N-] TZLVRPLSVNESQC-UHFFFAOYSA-N 0.000 description 1
- 239000011736 potassium bicarbonate Substances 0.000 description 1
- 235000015497 potassium bicarbonate Nutrition 0.000 description 1
- 229910000028 potassium bicarbonate Inorganic materials 0.000 description 1
- TYJJADVDDVDEDZ-UHFFFAOYSA-M potassium hydrogencarbonate Chemical compound [K+].OC([O-])=O TYJJADVDDVDEDZ-UHFFFAOYSA-M 0.000 description 1
- 229940086066 potassium hydrogencarbonate Drugs 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000002685 pulmonary effect Effects 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- AOJFQRQNPXYVLM-UHFFFAOYSA-N pyridin-1-ium;chloride Chemical compound [Cl-].C1=CC=[NH+]C=C1 AOJFQRQNPXYVLM-UHFFFAOYSA-N 0.000 description 1
- 229940070891 pyridium Drugs 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 125000004436 sodium atom Chemical group 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 125000004079 stearyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000008223 sterile water Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 239000000829 suppository Substances 0.000 description 1
- 239000000375 suspending agent Substances 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 229960003604 testosterone Drugs 0.000 description 1
- 150000005621 tetraalkylammonium salts Chemical class 0.000 description 1
- QEMXHQIAXOOASZ-UHFFFAOYSA-N tetramethylammonium Chemical compound C[N+](C)(C)C QEMXHQIAXOOASZ-UHFFFAOYSA-N 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 125000002889 tridecyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000002948 undecyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 230000008728 vascular permeability Effects 0.000 description 1
- 230000025033 vasoconstriction Effects 0.000 description 1
- 230000000304 vasodilatating effect Effects 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 238000013022 venting Methods 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
Landscapes
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
- Pyrane Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
Priority Applications (34)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP59172570A JPS6150977A (ja) | 1984-08-20 | 1984-08-20 | 新規な縮合ベンズ（チオ）アミド、それらの製造方法およびそれらを有効成分として含有する薬剤 |
| ZA856009A ZA856009B (en) | 1984-08-20 | 1985-08-08 | (fused)benz(thio)amides |
| CA000488741A CA1261835A (en) | 1984-08-20 | 1985-08-14 | (fused) benz(thio)amides |
| DE3588025T DE3588025T2 (de) | 1984-08-20 | 1985-08-15 | Aminophenylderivate. |
| AT85305802T ATE97897T1 (de) | 1984-08-20 | 1985-08-15 | (kondensierte) benz(thio)amide. |
| DE85305802T DE3587671T2 (de) | 1984-08-20 | 1985-08-15 | (Kondensierte) Benz(thio)amide. |
| EP85305802A EP0173516B1 (de) | 1984-08-20 | 1985-08-15 | (Kondensierte) Benz(thio)amide |
| AT91114142T ATE123019T1 (de) | 1984-08-20 | 1985-08-15 | Aminophenylderivate. |
| EP91114142A EP0463638B1 (de) | 1984-08-20 | 1985-08-15 | Aminophenylderivate |
| HU853184A HU208133B (en) | 1984-08-20 | 1985-08-17 | Process for producing condensed benzamide and benzthiamide derivatives and pharmaceutical compositions comprising same |
| IE940268A IE74959B1 (en) | 1984-08-20 | 1985-08-19 | Aminophenyl derivatives |
| SI8511321A SI8511321A8 (sl) | 1984-08-20 | 1985-08-19 | Postopek za pripravo (kondenziranih) benz(tio)amidov |
| FI853178A FI87782C (fi) | 1984-08-20 | 1985-08-19 | Foerfarande foer framstaellning av terapeutiskt anvaendbara kondenserade bens(tio)amider |
| PT80986A PT80986B (pt) | 1984-08-20 | 1985-08-19 | Processo para a preparacao de benzo(tio)amidas (condensadas) e de composicoes farmaceuticas que as contem |
| NO853261A NO159447C (no) | 1984-08-20 | 1985-08-19 | Analogifremgangsmaate for fremstilling av terapeutisk aktive (kondenserte)benz(tio)-amider. |
| KR1019850005970A KR920006237B1 (ko) | 1984-08-20 | 1985-08-19 | 융합된 벤즈(티오)아미드의 제조방법 |
| ES546269A ES8609217A1 (es) | 1984-08-20 | 1985-08-19 | Benzo(tio)amidas (fusionadas) nuevas |
| DK198503753A DK174022B1 (da) | 1984-08-20 | 1985-08-19 | Kondenserede benz(thio)amider, fremgangsmåde til deres fremstilling samt deres anvendelse til fremstilling af lægemidler |
| IE203585A IE64552B1 (en) | 1984-08-20 | 1985-08-19 | (Fused)benz(thio)amides |
| YU1321/85A YU45002B (en) | 1984-08-20 | 1985-08-19 | Process for preparing (condensed) benz(thio)amides |
| US06/767,538 US4780469A (en) | 1984-08-20 | 1985-08-20 | (Fused) benz(thio)amides and pharmaceutical use |
| GR852014A GR852014B (de) | 1984-08-20 | 1985-08-20 | |
| AU46462/85A AU579398B2 (en) | 1984-08-20 | 1985-08-20 | (Fused) Benz (Thio) Amides |
| ES552746A ES8704476A1 (es) | 1984-08-20 | 1986-03-06 | Un procedimiento para la preparacion de nuevas benzo(tio)amidas (fusionadas) |
| ES552747A ES8704455A1 (es) | 1984-08-20 | 1986-03-06 | Un procedimiento para la preparacion de nuevas benzo(tio)amidas (fusionadas) |
| ES552745A ES8800211A1 (es) | 1984-08-20 | 1986-03-06 | Un procedimiento para la preparacion de nuevas benzo(tio)amidas (fusionadas) |
| SI8711447A SI8711447A8 (sl) | 1984-08-20 | 1987-07-31 | Postopek za pripravo (kondenziranih) benzamidov |
| YU1447/87A YU44955B (en) | 1984-08-20 | 1987-07-31 | Process for preparing (condensed) benzamides |
| YU01446/87A YU144687A (en) | 1984-08-20 | 1987-07-31 | Process for preparing benz(thio)amides |
| YU01448/87A YU144887A (en) | 1984-08-20 | 1987-08-31 | Process for preparing benz(thio)amides |
| US07/207,994 US4847275A (en) | 1984-08-20 | 1988-06-17 | (Fused) benz (thio) amides |
| US07/332,930 US4939141A (en) | 1984-08-20 | 1989-04-04 | (Fused) benz (thio) amides and pharmaceutical compositions, thereof |
| US07/800,253 US5446058A (en) | 1984-08-20 | 1991-11-29 | (Fused) benz(thio)amides |
| US08/327,825 US5459134A (en) | 1984-08-20 | 1994-10-21 | (Fused) benz (thio) amides |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP59172570A JPS6150977A (ja) | 1984-08-20 | 1984-08-20 | 新規な縮合ベンズ（チオ）アミド、それらの製造方法およびそれらを有効成分として含有する薬剤 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS6150977A JPS6150977A (ja) | 1986-03-13 |
| JPH0430955B2 true JPH0430955B2 (de) | 1992-05-25 |
Family
ID=15944283
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP59172570A Granted JPS6150977A (ja) | 1984-08-20 | 1984-08-20 | 新規な縮合ベンズ（チオ）アミド、それらの製造方法およびそれらを有効成分として含有する薬剤 |
Country Status (2)
| Country | Link |
|---|---|
| JP (1) | JPS6150977A (de) |
| ZA (1) | ZA856009B (de) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2128510A1 (en) * | 1992-01-24 | 1993-08-05 | Tatsuki Shiota | Benzopyran derivatives, processes for production of the same, and pharmaceutical preparation containing the same as effective ingredient |
| JP2668483B2 (ja) * | 1992-05-29 | 1997-10-27 | キャシー・カザンジアン | ゴルフボール回収装置 |
| AU9002798A (en) * | 1997-09-19 | 1999-04-12 | Ono Pharmaceutical Co. Ltd. | Fused or nonfused benzene compounds |
| JP4752121B2 (ja) * | 2001-03-12 | 2011-08-17 | 住友化学株式会社 | ニトリル誘導体の製造方法、その中間体および中間体の製造方法 |
| EP1867626A3 (de) | 2002-02-28 | 2008-07-23 | Sumitomo Chemical Company, Limited | Procédé pour la préparation d'un dérivé de chromone |
| JPWO2005058878A1 (ja) * | 2003-12-16 | 2007-07-12 | 小野薬品工業株式会社 | 月経困難症の予防および／または治療剤 |
| KR20060120204A (ko) * | 2003-12-17 | 2006-11-24 | 각고우호징간사이이카다이가쿠 | 삼출성 중이염의 예방 및/또는 치료제 |
| JP4544856B2 (ja) * | 2003-12-25 | 2010-09-15 | 日医工株式会社 | プランルカスト水和物含有製剤 |
| JPWO2006003910A1 (ja) * | 2004-06-30 | 2008-04-17 | 小野薬品工業株式会社 | メニエール病の予防および／または治療剤 |
| KR100739439B1 (ko) | 2006-03-02 | 2007-07-13 | 주식회사 에스텍파마 | 8-아미노-4-옥소-2-(테트라졸-5-일)-4에이치-1-벤조피란 또는 그의 염의 제조방법 및 그의 제조용 중간체 |
| JP2011519916A (ja) * | 2008-07-02 | 2011-07-14 | ファーマコステック カンパニー リミテッド | アミド誘導体の製造方法 |
-
1984
- 1984-08-20 JP JP59172570A patent/JPS6150977A/ja active Granted
-
1985
- 1985-08-08 ZA ZA856009A patent/ZA856009B/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ZA856009B (en) | 1986-04-30 |
| JPS6150977A (ja) | 1986-03-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0173516B1 (de) | (Kondensierte) Benz(thio)amide | |
| US4755524A (en) | Novel phenolic thioethers as inhibitors of 5-lipoxygenase | |
| JPH057386B2 (de) | ||
| EP0202157B1 (de) | N-Substituierte 2-Aminothiazole, Verfahren zu ihrer Herstellung und ihre therapeutische Anwendung | |
| JPH0430955B2 (de) | ||
| JPH03173874A (ja) | 新規複素環化合物 | |
| JPH0739369B2 (ja) | フェニルプロピオン酸誘導体、その製造方法およびそれを有効成分として含有する薬剤 | |
| US4694018A (en) | Substituted 1,5-diphenyl-2-pyrrolepropionic acids and derivatives | |
| JPH0717589B2 (ja) | 新規１，３―ジカルボニル化合物およびその組成物 | |
| JP2004502684A (ja) | Ｃｏｍｔ阻害活性を有するクマリン誘導体 | |
| KR20150080425A (ko) | 1,2 나프토퀴논 유도체 및 이의 제조방법 | |
| JPS6097946A (ja) | カルボキサミド誘導体 | |
| IE920880A1 (en) | Tetronic and thiotetronic acid derivatives | |
| JPH0379337B2 (de) | ||
| US4801611A (en) | 5-lipoxygenase inhibitors | |
| EP0296732A1 (de) | Leukotrienantagonisten | |
| US5162365A (en) | 5-lipoxygenase inhibitors | |
| JPS60146855A (ja) | アニリン誘導体 | |
| JPH0425955B2 (de) | ||
| JPH0433785B2 (de) | ||
| JPH0247989B2 (de) | ||
| EP0313697B1 (de) | Leukotrien-Antagonisten | |
| JPH0684344B2 (ja) | ロイコトリエン拮抗剤 | |
| US5036105A (en) | 5-lipoxygenase inhibitors | |
| JPH056534B2 (de) |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EXPY | Cancellation because of completion of term | ||
| FPAY | Renewal fee payment (prs date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100525 Year of fee payment: 18 |